Genes such as H2BC21 were enriched in DNA repair pathways, highlighting their potential as therapeutic targets for sensitizing tumor cells to DNA‐damaging treatments such as chemotherapy and radiotherapy. This evidence concerns the gene H2BC21 and neoplasm.